Benjamin Bailly

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Clinical & translational immunology

mBio

ChemMedChem

Antimicrobial agents and chemotherapy

Institute for Glycomics, Griffith University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Institute for Glycomics, Griffith University

Australia

Research Scientist

Publications

Annelies Van Den Bergh, Benjamin Bailly, Patrice Guillon, Mark von Itzstein, Larissa Dirr
Novel insights into the host cell glycan binding profile of human metapneumovirus. Journal of virology (2024)
Annelies Van Den Bergh, Benjamin Bailly, Patrice Guillon, Mark von Itzstein, Larissa Dirr
Novel insights into the host cell glycan binding profile of human metapneumovirus. Journal of virology 98 (6) (2024)
Annelies Van Den Bergh, Benjamin Bailly, Patrice Guillon, Mark von Itzstein, Larissa Dirr
Novel insights into the host cell glycan binding profile of human metapneumovirus. Journal of virology 98 (6) (2024)
Annelies Van Den Bergh, Benjamin Bailly, Patrice Guillon, Mark von Itzstein, Larissa Dirr
Novel insights into the host cell glycan binding profile of human metapneumovirus. Journal of virology 98 (6) (2024)
Annelies Van Den Bergh, Benjamin Bailly, Patrice Guillon, Mark von Itzstein, Larissa Dirr
Novel insights into the host cell glycan binding profile of human metapneumovirus. Journal of virology 98 (6) (2024)
Annelies Van Den Bergh, Patrice Guillon, Mark von Itzstein, Benjamin Bailly, Larissa Dirr
Drug Repurposing for Therapeutic Discovery against Human Metapneumovirus Infection. Antimicrobial agents and chemotherapy 66 (10) (2022)
Mehfuz Zaman, Victor C Huber, Dustin L Heiden, Katerina N DeHaan, Sanyogita Chandra, Demi Erickson, Victoria Ozberk, Manisha Pandey, Benjamin Bailly, Gael Martin, Emma L Langshaw, Ali Zaid, Mark von Itzstein, Michael F Good
Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super-infection. Clinical & translational immunology 10 (9) (2021)
Benjamin Bailly, Anil Kumar Gorle, Larissa Dirr, Alpeshkumar K Malde, Nicholas P Farrell, Susan J Berners-Price, Mark von Itzstein
Platinum complexes act as shielding agents against virus infection. Chemical communications (Cambridge, England) 57 (38) (2021)
Kamalalayam Rajan Sreejith, Muhammad Umer, Larissa Dirr, Benjamin Bailly, Patrice Guillon, Mark von Itzstein, Narshone Soda, Surasak Kasetsirikul, Muhammad J A Shiddiky, Nam-Trung Nguyen
A Portable Device for LAMP Based Detection of SARS-CoV-2. Micromachines 12 (10) (2021)
Christopher J Day, Benjamin Bailly, Patrice Guillon, Larissa Dirr, Freda E-C Jen, Belinda L Spillings, Johnson Mak, Mark von Itzstein, Thomas Haselhorst, Michael P Jennings
Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions. mBio 12 (2) (2021)
Stef Meers, Benjamin Bailly, Isabelle Vande Broek, Bart Malfait, Sandra Van Hoorenbeeck, Janice Geers, Joost Braakman, Marieke Van Kouwenhove, Margaret Doyle, Joris Diels, Karin Caekelbergh, Pierre Chevalier, Daan Dierickx
Real-world data confirming the efficacy and safety of decitabine in acute myeloid leukaemia - results from a retrospective Belgian registry study. Acta clinica Belgica 76 (2) (2019)
Ádám Hadházi, Linghui Li, Benjamin Bailly, Andrea Maggioni, Gael Martin, Larissa Dirr, Jeffrey C Dyason, Robin J Thomson, George F Gao, Aniko Borbás, Thomas Ve, Mauro Pascolutti, Mark von Itzstein
A Sulfonozanamivir Analogue Has Potent Anti-influenza Virus Activity. ChemMedChem 13 (8) (2018)

Benjamin Bailly.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Benjamin Bailly